City of Hope to acquire Cancer Treatment Centers of America

Dewpoint Therapeutics and ConcertAI form drug development partnership

Dewpoint Therapeutics and ConcertAI announced the first phase of their Translational Oncology partnership, aligned around Dewpoint’s latest drug candidate, DPTX3186.

December 13, 2024

Vol.50 No.46

Clinical Roundup

Mushroom supplement may slow prostate cancer progression, City of Hope study finds

Researchers at City of Hope found that taking white button mushroom pills reduces a class of immune cells called myeloid-derived suppressor cells, which has been linked to cancer development and spread.

November 22, 2024

Vol.50 No.44

Clinical Trials & Tribulations

How we improved the treatment of Hodgkin lymphoma

Hodgkin lymphoma has long been a model disease in the field of oncology—one of the first diseases we learned to cure with radiation and ultimately chemotherapy.

Humana and Evolent expand partnership to enhance oncology care

Humana Inc. and Evolent Health Inc. announced an expansion of their strategic medical oncology partnership to modernize and streamline prior authorization processes to include radiation and surgical oncology services.

November 15, 2024

Vol.50 No.43

In Brief

Longevity Consortium receives $45M grant

The Longevity Consortium received a five-year, $45 million grant to move the consortium’s work to its next stage: integrating results from numerous studies about the factors that contribute to longer and healthier lives.

November 01, 2024

Vol.50 No.41

In Brief

Robert Jenq named director of microbiome program at City of Hope

Robert R. Jenq was named director of the microbiome program at City of Hope and clinical professor in the Department of Hematology and Hematopoietic Cell Transplantation.

September 20, 2024

Vol.50 No.35

City of Hope to acquire Cancer Treatment Centers of America

YOU MAY BE INTERESTED IN

Dewpoint Therapeutics and ConcertAI form drug development partnership

Mushroom supplement may slow prostate cancer progression, City of Hope study finds

How we improved the treatment of Hodgkin lymphoma

Humana and Evolent expand partnership to enhance oncology care

Longevity Consortium receives $45M grant

Robert Jenq named director of microbiome program at City of Hope

Renew today!

Subscriber content

Never miss an issue!

Login